Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
In addition to the Industry PhD Program Scholarship of $34,000 pa (GST exempt, indexed annually at 3%), there is an industry top-up component valued at $12,000 pa (not indexed). As such
-
in Engineering (e.g., Chemical, Materials, Environmental, Resources) or Chemistry (e.g., Inorganic Chemistry, Physical Chemistry, Electrochemistry) or equivalent degree. Students with previous research
-
by an ARC DECRA project. The purpose is to support the PhD candidate to conduct basic research on “Applications of oxide materials for electrochemical water splitting and plastic degradation”. The key
-
of this project should have a background in chemistry, physics or materials science with Honours 1 or Master’s by Research degree. It will be beneficial for them to have a relevant experience with techniques
-
will consist of an evaluation and exploration of the Department of Health's Bowel Cancer Screening Program (BCSP) in Western Australia. Participation in the WA program from 2019-2020 was 43.2% for adults
-
This opportunity is open to students with any science-oriented undergraduate background. Students with a background in physics/astronomy, mathematics/statistics, computer science, or data science are particularly
-
to microscopic viewpoints, master his/her comprehensive and in-depth knowledge related to material science, physics, and chemistry. The PhD candidate will work with Professors Moses Tade, Zongping Shao, and Early
-
About Data61 PhD Scholarships At CSIRO's Data61, we aim to develop top-quality doctoral students who will prosper in careers in Australia’s data-skilled workforce. Our PhD scholarship program
-
ablation in liquid ambient (Andrei Kabashin, Aix-Marseille University), fabrication of laser treated surfaces and their further coating by magnetic materials (RMIT in collaboration in Melbourne), and
-
treatment program for alexithymia. Significance Mental health disorders are among the largest sources of burden of disease across the world. A key treatment problem is that of 'comorbidity', whereby people